Clinical Trial Update: Application of PD-1 Inhibitors Combined With Tenofovir, Chidamide and Lenalidomide in the Treatment of EBV-associated Diseases. [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/Phase 2 trial is planned to evaluate a combination of PD-1 inhibitors with Tenofovir, Chidamide, and Lenalidomide for Epstein-Barr virus–associated di…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epstein-barr Virus Infection

Drugs mentioned

• Chidamide (chidamide)
• Lenalidomide (lenalidomide)
• PD-1 inhibitor
• Tenofovir (Tenofovir)

Snippet

Sponsor: The Affiliated Hospital of Xuzhou Medical University | Conditions: Epstein-Barr Virus (EBV) Infection, PD-1 Inhibitor | Phase 1, Phase 2 | Status: NOT_YET_RECRUITING